Bristol Myers Squibb Company
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bristol Myers Squibb Company
Finance Watch: Another VC Mega-Round As Flare Raises $123m Series B
Private Company Edition: Flare Therapeutics, targeting transcription factors to discover precision medicines, had big pharma backing for its second venture capital financing. Also, Mediar closed a $10m series A round, Switch launched with $52m and EpiBiologics raised a $50m series A round.
Gilead Waives Acquisition Option As Pionyr Explores Other Strategies
Gilead has waived its option to acquire Pionyr, allowing the US biotech to explore other partnerships and financing opportunities as it advances a promising pipeline of macrophage-targeting antibodies.
Biopharma Industry Sharply Divided Over Supreme Court Antibody Patent Brawl
Big biologic makers line up on opposite sides of dispute between Amgen and Sanofi over whether Amgen’s Repatha patents cover analogous antibodies with the same functional characteristics.
89bio’s Phase IIb Data Heighten Competition Within NASH FGF21 Analog Class
89bio’s pegozafermin met co-primary endpoints of fibrosis reduction and NASH resolution in Phase IIb; the company said its methodology yielded lower placebo responses than in Akero’s Phase IIb study.
- Other Names / Subsidiaries
- Abraxis BioScience, Inc.
- AbVitro, Inc.
- Acetylon Pharmaceuticals, Inc.
- Adnexus Therapeutics, Inc.
- Allied-Bristol Life Sciences, LLC
- Amira Pharmaceuticals, Inc.
- Amylin Pharmaceuticals, Inc.
- Avila Therapeutics, Inc.
- Bristol-Myers Company
- Bristol-Myers K.K.
- Bristol-Myers Squibb
- Cardioxyl Pharmaceuticals
- Celgene Corporation
- Cormorant Pharmaceuticals
- Delinia, Inc.
- EngMab AG
- Flexus Biosciences, Inc.
- Gloucester Pharmaceuticals, Inc.
- ißeCa Therapeutics
- IFM Therapeutics
- Impact Biomedicines, Inc.
- Inhibitex, Inc.
- iPierian Inc.
- Juno Therapeutics, Inc.
- Juno Therapeutics GmbH (Stage Cell Therapeutics GmbH)
- JW Biotechnology (Shanghai) Co., Ltd
- Medarex, Inc.
- Padlock Therapeutics, Inc.
- Pharmion Corporation
- Quanticel Pharmaceuticals, Inc.
- Receptos, Inc.
- RedoxTherapies, Inc.
- Turning Point Therapeutics Inc.
- Westwood-Squibb Pharmaceuticals
- X-BODY, Inc.
- ZymoGenetics, Inc.
- MyoKardia Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.